Pursuant to Regulations 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Board of Directors in its meeting held on today i.e. 22nd September 2022 has inter alia considered and approved to invest US$ 2.1 Million in USpharma Limited an USA based Company subject to compliance with Foreign Exchange Management (Overseas Investment) Rules, 2022 and Foreign Exchange Management (Overseas Investment) Regulations, 2022. USpharma Ltd., is an USA based Company that develop novel drug delivery technologies. The meeting of Board of Directors commenced at 6:00 PM and concluded at 6:42 PM. This is for your information & record.